News
Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease
8 Apr 24
Biotech, News, Health Care, FDA, Movers, General
12 Health Care Stocks Moving In Monday's Pre-Market Session
8 Apr 24
Movers
Supernus Provides Regulatory Update For SPN-830, FDA Has Issued A CRL In Response To The Co's NDA For Spn-830 Indicating That The Review Cycle For The Application Is Complete, But That The Application Is Not Ready For Approval In Its Present Form.
8 Apr 24
News
Piper Sandler Maintains Overweight on Supernus Pharmaceuticals, Lowers Price Target to $41
28 Feb 24
News, Price Target, Analyst Ratings
Recap: Supernus Pharmaceuticals Q4 Earnings
27 Feb 24
Earnings
Supernus Pharmaceuticals Q4 2023 Adj EPS $0.39 Misses $0.55 Estimate, Sales $164.31M Beat $155.03M Estimate
27 Feb 24
Earnings, Earnings Beats, Earnings Misses, News
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
Supernus Pharmaceuticals Wins Infringement And Validity Case On Trokendi XR
5 Feb 24
Biotech, News, Legal, General
Press releases
Supernus Provides Regulatory Update for SPN-830
8 Apr 24
Health Care, Press Releases, General
Supernus to Participate in Two Upcoming Investor Conferences
6 Mar 24
News, Press Releases
Thinking about buying stock in BigBear.ai, Supernus Pharmaceuticals, Collegium Pharmaceutical, Duolingo, or Cryptoblox Technologies?
5 Mar 24
Opinion, Press Releases
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
28 Feb 24
News, Press Releases
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
27 Feb 24
Earnings, Press Releases
Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
5 Feb 24
News, Legal, Press Releases